articleTop 1% cited
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Annals of Oncology · 2014 · Vol. 25(8) · pp. 1544–1550
Sherene Loi✉(Université Libre de Bruxelles)Stefan Michiels(Université Paris-Sud)Roberto Salgado(Institut Jules Bordet)Nicolas Sirtaine(Institut Jules Bordet)Vinu José(Université Libre de Bruxelles)Debora Fumagalli(Université Libre de Bruxelles)Pirkko Kellokumpu‐Lehtinen(Tampere University Hospital)Petri Bono(Helsinki University Hospital)Vesa Kataja(Kuopio University Hospital)Christine Desmedt(Université Libre de Bruxelles)Martine Piccart(Institut Jules Bordet)Sibylle Loibl(German Breast group)Carsten Denkert(Charité - Universitätsmedizin Berlin)Mark J. Smyth(The University of Queensland)Heikki Joensuu(Helsinki University Hospital)Christos Sotiriou(Université Libre de Bruxelles)
HER2/EGFR in Cancer ResearchCancer Immunotherapy and BiomarkersMonoclonal and Polyclonal Antibodies ResearchMedicineTrastuzumabOncologyBreast cancerInternal medicineCancerTriple-negative breast cancerTumor-infiltrating lymphocytesImmunotherapy
MeSH terms
TrastuzumabAdultAgedAntineoplastic Combined Chemotherapy ProtocolsFemaleFinlandHumansMiddle AgedNeoplasm StagingPredictive Value of TestsPrognosisBiomarkers, TumorLymphocytes, Tumor-InfiltratingTreatment OutcomeChemotherapy, Adjuvant
Citations
1,257
FWCI
57.42
field-weighted impact
References
42
Percentile
100%
vs. same field & year
Citations per year
Cited by
Prognostic and predictive value of PDL1 expression in breast cancer
Oncotarget · 2014 · 496 citations
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
Human Pathology · 2015 · 336 citations
Mechanisms of immune evasion in breast cancer
BMC Cancer · 2018 · 311 citations
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Annals of Oncology · 2014 · 3,065 citations
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
Annals of Oncology · 2015 · 1,820 citations
References
Proportional hazards tests and diagnostics based on weighted residuals
Biometrika · 1994 · 5,490 citations
A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer
Cancer Cell · 2007 · 1,609 citations
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Cancer Cell · 2004 · 1,856 citations
Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Nature Medicine · 2007 · 2,933 citations
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
JNCI Journal of the National Cancer Institute · 2005 · 2,064 citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Annals of Oncology · 2013 · 3,672 citations
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
Clinical Cancer Research · 2008 · 840 citations
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Nature Medicine · 2000 · 2,723 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.